Search
                    Carboplatin Treatment Options in South Carolina
A collection of 261 research studies where Carboplatin is the interventional treatment. These studies are located in the South Carolina, United States. Carboplatin is used for conditions such as Non-Small Cell Lung Cancer, Ovarian Cancer and Lung Cancer.
            205 - 216 of 261
        Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    
                
                                    Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary
                                
            
            
        Completed
                            
            
                The purpose of this study is to assess efficacy and safety of belinostat in combination with carboplatin and paclitaxel in patients with previously untreated carcinoma of unknown primary.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                07/07/2015
            
            Locations: South Carolina Oncology Associates, Columbia, South Carolina         
        
        
            Conditions: Carcinoma of Unknown Primary
        
            
        
    
                
                                    Trial of Poor Performance Status Patients (ToPPS)
                                
            
            
        Completed
                            
            
                The purpose of this trial is to evaluate three treatment regimens in patients with stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) with a performance status of 2 and who were not previously treated.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/12/2015
            
            Locations: Medical University of South Carolina, Charlston, South Carolina  +2 locations         
        
        
            Conditions: Non Small Cell Lung Cancer
        
            
        
    
                
                                    High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy, such as carboplatin, thiotepa, and etoposide, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with autologous stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. Isotretinoin may be effective in preventing recurrence of glioma. It is not yet known which regimen of chemotherapy plus autologous stem cell transplantation with or without...  Read More             
        
        
    Gender:
                ALL
            Ages:
                20 years and below
            Trial Updated:
                05/06/2015
            
            Locations: Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina         
        
        
            Conditions: Brain Tumor, Central Nervous System Tumor
        
            
        
    
                
                                    A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
                                
            
            
        Terminated
                            
            
                This is a randomized trial to estimate the activity of R-ICE plus SGN-40 vs. R-ICE plus placebo in patients with DLBCL. The study will assess safety and tolerability and will measure any additional clinical benefit observed in patients receiving SGN-40.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 75 years
            Trial Updated:
                02/06/2015
            
            Locations: Medical University of South Carolina, Charleston, South Carolina         
        
        
            Conditions: Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin
        
            
        
    
                
                                    Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
                                
            
            
        Completed
                            
            
                The purpose of this study is to compare the progression-free survival of two treatment regimens for relapsed ovarian cancer.             
        
        
    Gender:
                FEMALE
            Ages:
                18 years and above
            Trial Updated:
                02/05/2015
            
            Locations: MUSC-Div of Gyn/Oncology, Charleston, South Carolina         
        
        
            Conditions: Ovarian Cancer
        
            
        
    
                
                                    Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer
                                
            
            
        Completed
                            
            
                This trial will compare the efficacy and toxicity of standard first-line chemotherapy alone vs. standard chemotherapy plus sorafenib in patients with stage III/IV ovarian cancer following cytoreductive surgery. Patients with residual large volume disease and/or bowel involvement will be excluded, to minimize the risk of bowel perforation.             
        
        
    Gender:
                FEMALE
            Ages:
                18 years and above
            Trial Updated:
                12/12/2014
            
            Locations: South Carolina Oncology Associates, PA, Columbia, South Carolina         
        
        
            Conditions: Ovarian Cancer
        
            
        
    
                
                                    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
                                
            
            
        Completed
                            
            
                RATIONALE: Amifostine may be an effective treatment for the toxic side effects caused by radiation therapy and chemotherapy. It is not yet known whether chemotherapy and radiation therapy are more effective with or without amifostine for non-small cell lung cancer.
PURPOSE: Randomized phase III trial to determine the effectiveness of amifostine in treating patients who have stage II or stage III non-small cell lung cancer that cannot be surgically removed and who are undergoing chemotherapy and...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                11/19/2014
            
            Locations: Medical University of South Carolina, Charleston, South Carolina  +2 locations         
        
        
            Conditions: Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
        
            
        
    
                
                                    Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
                                
            
            
        Completed
                            
            
                The purpose of this Phase 3 study is to evaluate overall survival and progression free survival following intravenous administration of REOLYSIN (Reovirus Serotype 3 Dearing) in combination with paclitaxel and carboplatin versus chemotherapy treatment alone, in patients with metastatic or recurrent Squamous Cell Carcinoma of the Head and Neck.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                11/03/2014
            
            Locations: Medical University of South Carolina, Charleston, South Carolina         
        
        
            Conditions: Carcinoma, Squamous Cell of the Head and Neck
        
            
        
    
                
                                    A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)
                                
            
            
        Terminated
                            
            
                A randomized controlled trial comparing safety and efficacy of carboplatin and paclitaxel plus or minus sorafenib in chemonaive patients with stage III-IV non-small cell lung cancer.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                10/28/2014
            
            Locations: Not set, Charleston, South Carolina  +1 locations         
        
        
            Conditions: Carcinoma, Non-Small Cell Lung
        
            
        
    
                
                                    Combination Chemotherapy in Treating Children With Neuroblastoma
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Combination chemotherapy plus surgery may be an effective treatment for neuroblastoma.
PURPOSE: This phase III trial is studying how well combination chemotherapy followed by surgery works in treating young patients with neuroblastoma.             
        
        
    Gender:
                ALL
            Ages:
                20 years and below
            Trial Updated:
                07/31/2014
            
            Locations: Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina  +2 locations         
        
        
            Conditions: Neuroblastoma
        
            
        
    
                
                                    Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. It is not yet known which therapy regimen is most effective for treating patients with kidney tumors.
PURPOSE: Phase III trial to compare the effectiveness of...  Read More             
        
        
    Gender:
                ALL
            Ages:
                21 years and below
            Trial Updated:
                07/23/2014
            
            Locations: Medical University of South Carolina, Charleston, South Carolina  +2 locations         
        
        
            Conditions: Kidney Cancer
        
            
        
    
                
                                    Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
                                
            
            
        Terminated
                            
            
                This randomized phase III trial is studying carboplatin, paclitaxel, radiation therapy, and thalidomide to see how well they work compared to carboplatin, paclitaxel, and radiation therapy alone in treating patients with newly diagnosed stage III non-small cell lung cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Thalidomide may stop the growth of non-small cell lung cancer by stopping blood flow to the tumor. It is not yet kno...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/29/2014
            
            Locations: Cancer Care Institute of Carolina at Aiken Regional Medical Centers, Aiken, South Carolina  +1 locations         
        
        
            Conditions: Lung Cancer
        
            
        
    205 - 216 of 261
            